Dalian Bio-Chem Co Ltd
Dalian BIO-CHEM Company Limited researches, develops, produces, and sells industrial fungicides in China and internationally. It offers various isothiazolinone fungicides, including CMIT/MIT, MIT, OIT, DCOIT, and BIT series products; and OEM/ODM services. The company was founded in 2003 and is headquartered in Dalian, China.
Market Cap & Net Worth: Dalian Bio-Chem Co Ltd (603360)
Dalian Bio-Chem Co Ltd (SHG:603360) has a market capitalization of $2.52 Billion (CN¥18.52 Billion) as of March 19, 2026. Listed on the SHG stock exchange, this China-based company holds position #7414 globally and #1258 in its home market, demonstrating a -1.43% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dalian Bio-Chem Co Ltd's stock price CN¥26.23 by its total outstanding shares 706223654 (706.22 Million).
Dalian Bio-Chem Co Ltd Market Cap History: 2017 to 2026
Dalian Bio-Chem Co Ltd's market capitalization history from 2017 to 2026. Data shows growth from $630.27 Million to $2.52 Billion (21.88% CAGR).
Dalian Bio-Chem Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Dalian Bio-Chem Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.63x
Dalian Bio-Chem Co Ltd's market cap is 1.63 times its annual revenue
0.59x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
6.20x
Dalian Bio-Chem Co Ltd's market cap is 6.20 times its annual earnings
710.94x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $630.27 Million | $410.36 Million | $100.27 Million | 1.54x | 6.29x |
| 2018 | $518.80 Million | $528.17 Million | $145.19 Million | 0.98x | 3.57x |
| 2019 | $1.49 Billion | $871.90 Million | $306.80 Million | 1.70x | 4.84x |
| 2020 | $935.73 Million | $749.54 Million | $221.75 Million | 1.25x | 4.22x |
| 2021 | $832.16 Million | $1.01 Billion | $250.49 Million | 0.83x | 3.32x |
| 2022 | $1.12 Billion | $1.26 Billion | $402.57 Million | 0.89x | 2.79x |
| 2023 | $1.02 Billion | $1.07 Billion | $328.38 Million | 0.95x | 3.10x |
| 2024 | $2.14 Billion | $1.31 Billion | $345.26 Million | 1.63x | 6.20x |
Competitor Companies of 603360 by Market Capitalization
Companies near Dalian Bio-Chem Co Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Dalian Bio-Chem Co Ltd by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #71 globally with a market cap of $210.18 Billion USD.
- L'Air Liquide S.A (PINK:AIQUF): Ranked #182 globally with a market cap of $107.70 Billion USD.
- Air Liquide SA (PA:AI): Ranked #200 globally with a market cap of $99.38 Billion USD ( €96.82 Billion EUR).
- Ecolab Inc (NYSE:ECL): Ranked #266 globally with a market cap of $77.81 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #71 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $494.05 |
| #182 | L'Air Liquide S.A | PINK:AIQUF | $107.70 Billion | $187.03 |
| #200 | Air Liquide SA | PA:AI | $99.38 Billion | €172.22 |
| #266 | Ecolab Inc | NYSE:ECL | $77.81 Billion | $272.59 |
Dalian Bio-Chem Co Ltd Historical Marketcap From 2017 to 2026
Between 2017 and today, Dalian Bio-Chem Co Ltd's market cap moved from $630.27 Million to $ 2.52 Billion, with a yearly change of 21.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥2.52 Billion | -18.59% |
| 2025 | CN¥3.10 Billion | +44.81% |
| 2024 | CN¥2.14 Billion | +110.50% |
| 2023 | CN¥1.02 Billion | -9.26% |
| 2022 | CN¥1.12 Billion | +34.74% |
| 2021 | CN¥832.16 Million | -11.07% |
| 2020 | CN¥935.73 Million | -37.04% |
| 2019 | CN¥1.49 Billion | +186.50% |
| 2018 | CN¥518.80 Million | -17.69% |
| 2017 | CN¥630.27 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Dalian Bio-Chem Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.52 Billion USD |
| MoneyControl | $2.52 Billion USD |
| MarketWatch | $2.52 Billion USD |
| marketcap.company | $2.52 Billion USD |
| Reuters | $2.52 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.